Skip to content
BioNTech
-
BioNTech closes Singapore manufacturing plant as COVID-19 vaccine demand collapses
BioNTech’s decision follows a comprehensive strategic review aimed at aligning the company’s manufacturing capacity with its clinical pipeline and long-term business direction